Y Intercept Hong Kong Ltd Purchases 17,360 Shares of Nutrien Ltd. (NYSE:NTR)

Y Intercept Hong Kong Ltd boosted its holdings in Nutrien Ltd. (NYSE:NTR - Free Report) by 63.5% in the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 44,704 shares of the company's stock after buying an additional 17,360 shares during the quarter. Y Intercept Hong Kong Ltd's holdings in Nutrien were worth $2,148,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Silchester International Investors LLP grew its position in Nutrien by 164.4% in the 3rd quarter. Silchester International Investors LLP now owns 10,683,242 shares of the company's stock worth $513,437,000 after purchasing an additional 6,642,075 shares during the period. Healthcare of Ontario Pension Plan Trust Fund purchased a new stake in Nutrien during the third quarter valued at $150,181,000. Bank of Montreal Can lifted its holdings in Nutrien by 15.5% in the second quarter. Bank of Montreal Can now owns 13,354,385 shares of the company's stock valued at $719,668,000 after acquiring an additional 1,794,333 shares during the period. Clal Insurance Enterprises Holdings Ltd boosted its position in Nutrien by 78.8% in the third quarter. Clal Insurance Enterprises Holdings Ltd now owns 2,495,282 shares of the company's stock worth $121,271,000 after purchasing an additional 1,100,000 shares during the last quarter. Finally, National Bank of Canada FI grew its stake in shares of Nutrien by 34.0% during the 2nd quarter. National Bank of Canada FI now owns 4,066,629 shares of the company's stock valued at $205,385,000 after purchasing an additional 1,032,763 shares during the period. Institutional investors own 63.10% of the company's stock.

Nutrien Price Performance

Shares of Nutrien stock traded down $0.23 during trading on Tuesday, reaching $48.55. 1,968,259 shares of the stock traded hands, compared to its average volume of 1,958,993. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.27 and a quick ratio of 0.82. The company has a market capitalization of $23.98 billion, a price-to-earnings ratio of 32.58, a P/E/G ratio of 1.69 and a beta of 0.80. Nutrien Ltd. has a 52-week low of $44.65 and a 52-week high of $60.87. The business has a fifty day simple moving average of $47.97 and a two-hundred day simple moving average of $49.26.

Nutrien (NYSE:NTR - Get Free Report) last released its quarterly earnings data on Wednesday, November 6th. The company reported $0.39 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.43 by ($0.04). Nutrien had a return on equity of 6.99% and a net margin of 2.79%. The firm had revenue of $5.35 billion during the quarter, compared to the consensus estimate of $5.26 billion. During the same period in the previous year, the firm earned $0.35 EPS. The business's revenue was down 5.0% compared to the same quarter last year. Sell-side analysts expect that Nutrien Ltd. will post 3.54 EPS for the current year.

Nutrien Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 17th. Shareholders of record on Tuesday, December 31st will be paid a $0.939 dividend. This is a boost from Nutrien's previous quarterly dividend of $0.54. This represents a $3.76 dividend on an annualized basis and a dividend yield of 7.74%. The ex-dividend date of this dividend is Tuesday, December 31st. Nutrien's dividend payout ratio (DPR) is presently 144.97%.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on NTR. Barclays cut their target price on shares of Nutrien from $68.00 to $55.00 and set an "overweight" rating for the company in a research report on Friday, August 16th. Wells Fargo & Company lowered Nutrien from an "overweight" rating to an "equal weight" rating and reduced their price objective for the stock from $62.00 to $50.00 in a research note on Tuesday, September 24th. The Goldman Sachs Group downgraded Nutrien from a "buy" rating to a "neutral" rating and lowered their target price for the company from $69.00 to $53.00 in a research report on Tuesday, September 10th. Raymond James upgraded Nutrien from a "market perform" rating to an "outperform" rating and upped their price target for the stock from $58.00 to $60.00 in a research report on Tuesday, December 3rd. Finally, TD Securities lowered their price objective on Nutrien from $63.00 to $61.00 and set a "buy" rating on the stock in a research report on Tuesday, November 12th. Three equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and ten have assigned a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of "Hold" and a consensus price target of $58.89.

About Nutrien

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.